BioAffinity Technologies Inc (NASDAQ:BIAF) shares, rose in value, with the stock price up by 9.67% to the previous day’s close as strong demand from buyers drove the stock to $0.51.
Actively observing the price movement in the last trading, the stock closed the session at $0.47, falling within a range of $0.488 and $0.58. The value of beta (5-year monthly) was 3.469. Referring to stock’s 52-week performance, its high was $3.16, and the low was $0.24. On the whole, BIAF has fluctuated by 79.76% over the past month.
With the market capitalization of BioAffinity Technologies Inc currently standing at about $9.40 million, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-Mar-30.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that BIAF’s technical picture suggests that short-term indicators denote the stock is a 50% Sell on average. However, medium-term indicators have put the stock in the category of 100% Sell while long-term indicators on average have been pointing out that it is a 100% Sell.
The stock’s technical analysis shows that the price of BIAF currently trading nearly 0.14% and -4.94% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 49.38, while the 7-day volatility ratio is showing 13.41% which for the 30-day chart, stands at 26.02%. Furthermore, BioAffinity Technologies Inc (BIAF)’s beta value is 1.94, and its average true range (ATR) is 0.13.
A comparison of BioAffinity Technologies Inc (BIAF) with its peers suggests the former has fared considerably weaker in the market. BIAF showed an intraday change of 9.67% in last session, and over the past year, it shrunk by -81.80%%.
Data on historical trading for BioAffinity Technologies Inc (NASDAQ:BIAF) indicates that the trading volumes over the past 10 days have averaged 0.75 and over the past 3 months, they’ve averaged 9.53 million. According to company’s latest data on outstanding shares, there are 15.58 million shares outstanding.
Nearly 39.53% of BioAffinity Technologies Inc’s shares belong to company insiders and institutional investors own 2.94% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 0.25 million shares as on 2025-03-31, resulting in a short ratio of 0.11. According to the data, the short interest in BioAffinity Technologies Inc (BIAF) stood at 207.00 of shares outstanding as of 2025-03-31; the number of short shares registered in 2025-02-28 reached 0.12 million. The stock has fallen by -43.41% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the BIAF stock heading into the next quarter.
